Literature DB >> 23103491

Baseline smoking status and the long-term risk of death or nonfatal vascular event in people with stroke: a 10-year survival analysis.

Joosup Kim1, Seana L Gall, Helen M Dewey, Richard A L Macdonell, Jonathan W Sturm, Amanda G Thrift.   

Abstract

BACKGROUND AND
PURPOSE: Smoking may exacerbate the risk of death or further vascular events in those with stroke, but data are limited.
METHODS: 1589 cases of first-ever and recurrent stroke were recruited between 1996 and 1999 from a defined geographical region in North East Melbourne. Both hospital and nonhospital cases were included. Over a 10-year period, all deaths, recurrent stroke events, and acute myocardial infarctions that were reported at follow-up interviews were validated using medical records. Cox proportional hazards regression was used to assess the association between baseline smoking status (never, ex, and current) and outcome (death, acute myocardial infarction, or recurrent stroke).
RESULTS: Patients who were current smokers (Hazard Ratio [HR], 1.30; 95% Confidence Interval [CI], 1.06-1.60; P=0.012) at the time of their stroke had poorer outcome when compared with those who had never smoked. Among those who survived the first 28 days of stroke, current smokers (HR, 1.42; 95% CI, 1.13-1.78; P<0.003) and ex-smokers (HR, 1.18; 95% CI, 1.01-1.39; P=0.039) at baseline had poorer outcome than those who had never smoked. Current smokers also had a greater risk of recurrent events than past smokers (HR, 1.23; 95% CI, 1.00-1.50; P=0.050).
CONCLUSIONS: Patients who smoked at the time of their stroke or had smoked before their stroke had greater risk of death or recurrent vascular events when compared with patients who were never smokers. There are benefits of smoking cessation, with ex-smokers appearing to have a lesser risk of recurrent vascular events than current smokers.

Entities:  

Mesh:

Year:  2012        PMID: 23103491     DOI: 10.1161/STROKEAHA.112.668905

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents.

Authors:  Hui Chen; David Simar; Katherine Pegg; Sonia Saad; Clovis Palmer; Margaret J Morris
Journal:  Diabetologia       Date:  2013-12-14       Impact factor: 10.122

Review 2.  Advances in stroke prevention.

Authors:  Ayesha Z Sherzai; Mitchell S V Elkind
Journal:  Ann N Y Acad Sci       Date:  2015-03       Impact factor: 5.691

3.  Smoking and mortality in stroke survivors: can we eliminate the paradox?

Authors:  Deborah A Levine; James M Walter; Sudeep J Karve; Lesli E Skolarus; Steven R Levine; Kristine A Mulhorn
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-15       Impact factor: 2.136

4.  Smoking cessation and outcome after ischemic stroke or TIA.

Authors:  Katherine A Epstein; Catherine M Viscoli; J David Spence; Lawrence H Young; Silvio E Inzucchi; Mark Gorman; Brett Gerstenhaber; Peter D Guarino; Anand Dixit; Karen L Furie; Walter N Kernan
Journal:  Neurology       Date:  2017-09-08       Impact factor: 9.910

5.  Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke/transient ischemic attack.

Authors:  Yih-Ru Chen; Fang-I Hsieh; Li-Ming Lien; Chaur-Jong Hu; Jiann-Shing Jeng; Giia-Sheun Peng; Sung-Chun Tang; Nai-Fang Chi; Yueh-Feng Sung; Hung-Yi Chiou
Journal:  J Neurol       Date:  2018-06-02       Impact factor: 4.849

6.  Smoking is Not a Good Prognostic Factor following First-Ever Acute Ischemic Stroke.

Authors:  Ju-Hun Lee; Ju Young Lee; So Hyun Ahn; Min Uk Jang; Mi Sun Oh; Chul-Ho Kim; Kyung-Ho Yu; Byung-Chul Lee
Journal:  J Stroke       Date:  2015-05-29       Impact factor: 6.967

7.  Impact of Smoking Status on Stroke Recurrence.

Authors:  Jingjing Chen; Shun Li; Kuo Zheng; Huaiming Wang; Yi Xie; Pengfei Xu; Zhengze Dai; Mengmeng Gu; Yaqian Xia; Min Zhao; Xinfeng Liu; Gelin Xu
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

8.  Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.

Authors:  Neal S Parikh; Setareh Salehi Omran; Hooman Kamel; Mitchell S V Elkind; Joshua Z Willey
Journal:  J Clin Neurosci       Date:  2020-04-22       Impact factor: 1.961

9.  Stroke types in rural and urban northern portugal: incidence and 7-year survival in a community-based study.

Authors:  Manuel Correia; Rui Magalhães; Mário Rui Silva; Ilda Matos; Maria Carolina Silva
Journal:  Cerebrovasc Dis Extra       Date:  2013-10-18

10.  Stroke in-hospital survival and its predictors: the first results from Tabriz Stroke Registry of Iran.

Authors:  Reza Deljavan; Mehdi Farhoudi; Homayoun Sadeghi-Bazargani
Journal:  Int J Gen Med       Date:  2018-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.